Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate

Abstract Background The currently used malaria vaccine, RTS,S, is designed based on the Plasmodium falciparum circumsporozoite protein (PfCSP). The pfcsp gene, besides having different polymorphic patterns, can vary between P. falciparum isolates due to geographical origin and host immune response....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nouh Saad Mohamed, Hanadi AbdElbagi, Ahad R. Elsadig, Abdalla Elssir Ahmed, Yassir Osman Mohammed, Lubna Taj Elssir, Mohammed-Ahmed B. Elnour, Yousif Ali, Mohamed S. Ali, Omnia Altahir, Mustafa Abubakr, Emmanuel Edwar Siddig, Ayman Ahmed, Rihab Ali Omer
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/c38b2d8c550f4b60b6ee2714a1922d8a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c38b2d8c550f4b60b6ee2714a1922d8a
record_format dspace
spelling oai:doaj.org-article:c38b2d8c550f4b60b6ee2714a1922d8a2021-11-14T12:33:46ZAssessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate10.1186/s12936-021-03971-01475-2875https://doaj.org/article/c38b2d8c550f4b60b6ee2714a1922d8a2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12936-021-03971-0https://doaj.org/toc/1475-2875Abstract Background The currently used malaria vaccine, RTS,S, is designed based on the Plasmodium falciparum circumsporozoite protein (PfCSP). The pfcsp gene, besides having different polymorphic patterns, can vary between P. falciparum isolates due to geographical origin and host immune response. Such aspects are essential when considering the deployment of the RTS,S vaccine in a certain region. Therefore, this study assessed the genetic diversity of P. falciparum in Sudan based on the pfcsp gene by investigating the diversity at the N-terminal, central repeat, and the C-terminal regions. Methods A cross-sectional molecular study was conducted; P. falciparum isolates were collected from different health centres in Khartoum State between January and December 2019. During the study period, a total of 261 febrile patients were recruited. Malaria diagnosis was made by expert microscopists using Giemsa-stained thick and thin blood films. DNA samples were examined by the semi-nested polymerase chain reaction (PCR). Single clonal infection of the confirmed P. falciparum cases, were used to amplify the pfcsp gene. The amplified amplicons of pfcsp have been sequenced using the Sanger dideoxy method. The obtained sequences of pfcsp nucleotide diversity parameters including the numbers of haplotypes (Hap), haplotypes diversity (Hapd), the average number of nucleotide differences between two sequences (p), and the numbers of segregating sites (S) were obtained. The haplotype networks were constructed using the online tcsBU software. Natural selection theory was also tested on pfcsp using Fuand Li’s D, Fuand Li’s F statistics, and Tajima’s D test using DnaSP. Results In comparison with the different pfcsp reference strains, the Sudanese isolates showed high similarity with other African isolates. The results of the N-terminal region showed the presence of 2 different haplotypes with a Hapd of 0.425 ± 0.00727. The presence of the unique insertion of NNNGDNGREGKDEDKRDGNN was reported. The KLKQP motif was conserved in all the studied isolates. At the central repeat region, 11 haplotypes were seen with a Hapd of 0.779 ± 0.00097. The analysis of the genetic diversity in the C-terminal region showed the presence of 10 haplotypes with a Hapd of 0.457 ± 0.073. Several non-synonymous amino acids changes were also seen at the Th2R and the Th3R T-cell epitope regions including T317K, E317K, Q318E, K321N, I322K, T322K, R322K, K324Q, I327L, G352N, S354P, R355K, N356D, Q357E, and E361A. Conclusions In this study, the results indicated a high conservation at the pfcsp gene. This may further contribute in understanding the genetic polymorphisms of P. falciparum prior to the deployment of the RTS,S vaccine in Sudan.Nouh Saad MohamedHanadi AbdElbagiAhad R. ElsadigAbdalla Elssir AhmedYassir Osman MohammedLubna Taj ElssirMohammed-Ahmed B. ElnourYousif AliMohamed S. AliOmnia AltahirMustafa AbubakrEmmanuel Edwar SiddigAyman AhmedRihab Ali OmerBMCarticleMalariaPlasmodium falciparum circumsporozoite protein (PfCSP)VaccineRTS,SHapdN-terminal, central repeats, and C-terminal regionsArctic medicine. Tropical medicineRC955-962Infectious and parasitic diseasesRC109-216ENMalaria Journal, Vol 20, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Malaria
Plasmodium falciparum circumsporozoite protein (PfCSP)
Vaccine
RTS,S
Hapd
N-terminal, central repeats, and C-terminal regions
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
spellingShingle Malaria
Plasmodium falciparum circumsporozoite protein (PfCSP)
Vaccine
RTS,S
Hapd
N-terminal, central repeats, and C-terminal regions
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Nouh Saad Mohamed
Hanadi AbdElbagi
Ahad R. Elsadig
Abdalla Elssir Ahmed
Yassir Osman Mohammed
Lubna Taj Elssir
Mohammed-Ahmed B. Elnour
Yousif Ali
Mohamed S. Ali
Omnia Altahir
Mustafa Abubakr
Emmanuel Edwar Siddig
Ayman Ahmed
Rihab Ali Omer
Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
description Abstract Background The currently used malaria vaccine, RTS,S, is designed based on the Plasmodium falciparum circumsporozoite protein (PfCSP). The pfcsp gene, besides having different polymorphic patterns, can vary between P. falciparum isolates due to geographical origin and host immune response. Such aspects are essential when considering the deployment of the RTS,S vaccine in a certain region. Therefore, this study assessed the genetic diversity of P. falciparum in Sudan based on the pfcsp gene by investigating the diversity at the N-terminal, central repeat, and the C-terminal regions. Methods A cross-sectional molecular study was conducted; P. falciparum isolates were collected from different health centres in Khartoum State between January and December 2019. During the study period, a total of 261 febrile patients were recruited. Malaria diagnosis was made by expert microscopists using Giemsa-stained thick and thin blood films. DNA samples were examined by the semi-nested polymerase chain reaction (PCR). Single clonal infection of the confirmed P. falciparum cases, were used to amplify the pfcsp gene. The amplified amplicons of pfcsp have been sequenced using the Sanger dideoxy method. The obtained sequences of pfcsp nucleotide diversity parameters including the numbers of haplotypes (Hap), haplotypes diversity (Hapd), the average number of nucleotide differences between two sequences (p), and the numbers of segregating sites (S) were obtained. The haplotype networks were constructed using the online tcsBU software. Natural selection theory was also tested on pfcsp using Fuand Li’s D, Fuand Li’s F statistics, and Tajima’s D test using DnaSP. Results In comparison with the different pfcsp reference strains, the Sudanese isolates showed high similarity with other African isolates. The results of the N-terminal region showed the presence of 2 different haplotypes with a Hapd of 0.425 ± 0.00727. The presence of the unique insertion of NNNGDNGREGKDEDKRDGNN was reported. The KLKQP motif was conserved in all the studied isolates. At the central repeat region, 11 haplotypes were seen with a Hapd of 0.779 ± 0.00097. The analysis of the genetic diversity in the C-terminal region showed the presence of 10 haplotypes with a Hapd of 0.457 ± 0.073. Several non-synonymous amino acids changes were also seen at the Th2R and the Th3R T-cell epitope regions including T317K, E317K, Q318E, K321N, I322K, T322K, R322K, K324Q, I327L, G352N, S354P, R355K, N356D, Q357E, and E361A. Conclusions In this study, the results indicated a high conservation at the pfcsp gene. This may further contribute in understanding the genetic polymorphisms of P. falciparum prior to the deployment of the RTS,S vaccine in Sudan.
format article
author Nouh Saad Mohamed
Hanadi AbdElbagi
Ahad R. Elsadig
Abdalla Elssir Ahmed
Yassir Osman Mohammed
Lubna Taj Elssir
Mohammed-Ahmed B. Elnour
Yousif Ali
Mohamed S. Ali
Omnia Altahir
Mustafa Abubakr
Emmanuel Edwar Siddig
Ayman Ahmed
Rihab Ali Omer
author_facet Nouh Saad Mohamed
Hanadi AbdElbagi
Ahad R. Elsadig
Abdalla Elssir Ahmed
Yassir Osman Mohammed
Lubna Taj Elssir
Mohammed-Ahmed B. Elnour
Yousif Ali
Mohamed S. Ali
Omnia Altahir
Mustafa Abubakr
Emmanuel Edwar Siddig
Ayman Ahmed
Rihab Ali Omer
author_sort Nouh Saad Mohamed
title Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
title_short Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
title_full Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
title_fullStr Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
title_full_unstemmed Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
title_sort assessment of genetic diversity of plasmodium falciparum circumsporozoite protein in sudan: the rts,s leading malaria vaccine candidate
publisher BMC
publishDate 2021
url https://doaj.org/article/c38b2d8c550f4b60b6ee2714a1922d8a
work_keys_str_mv AT nouhsaadmohamed assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT hanadiabdelbagi assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT ahadrelsadig assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT abdallaelssirahmed assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT yassirosmanmohammed assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT lubnatajelssir assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT mohammedahmedbelnour assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT yousifali assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT mohamedsali assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT omniaaltahir assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT mustafaabubakr assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT emmanueledwarsiddig assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT aymanahmed assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
AT rihabaliomer assessmentofgeneticdiversityofplasmodiumfalciparumcircumsporozoiteproteininsudanthertssleadingmalariavaccinecandidate
_version_ 1718429191930642432